eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
6/2008
vol. 3
 
Share:
Send email
Share:
abstract:

Influence of inflammatory bowel disease on fertility, pregnancy and delivery outcom

Piotr Radwan
,
Karolina Radwan-Kwiatek
,
Maciej Kwiatek
,
Barbara Skrzydło-Radomańska

Przegląd Gastroenterologiczny 2008; 3 (6): 295–301
Online publish date: 2009/01/16
View full text Get citation
 
Inflammatory bowel disease (IBD), consisting of ulcerative colitis and Crohn’s disease, primarily affects young people during their peak reproductive years. The impact of disease activity status and its treatment on fertility, pregnancy and delivery outcome as well as the clinical management strategies with pregnant women and IBD patients in their periconceptive period are therefore an important clinical interdisciplinary question. Overall, neither IBD nor the majority of drugs used in IBD affect the ability to conceive in humans. Treatment with sulphasalazine has been shown to reversibly decrease male fertility. The disease severity at time of conception and during pregnancy is associated with higher risk of adverse pregnancy-related outcomes and perinatal complications. The basic rule for IBD management is appropriate proactive treatment for maintenance of remission during gestation. Most drugs used in IBD are considered safe in pregnancy.
keywords:

inflammatory bowel disease, treatment, pregnancy, fertility
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.